Evidence map›Paper›PMID 41757378›Full record

ArticleJHEP reports : innovation in hepatology2026

Proctocolectomy with permanent ileostomy is associated with improved transplant-free survival in patients with PSC.

Bregje Mol, Moyrha van Nieuwamerongen, Kim N van Munster, Martti Färkkilä, Trine Folseraas, Sara K V Tjønnfjord, Johannes R Hov, Kirsten Boberg, Mette Vesterhus, Kristin K Jørgensen and 9 more

Abstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Bregje MolDepartment of Gastroenterology and Hepatology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Moyrha van NieuwamerongenDepartment of Gastroenterology and Hepatology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Kim N van MunsterDepartment of Gastroenterology and Hepatology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Martti FärkkiläDepartment of Gastroenterology and Hepatology, Helsinki University Hospital, Helsinki, Finland.
Trine FolseraasNorwegian PSC Research Centre, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
Sara K V TjønnfjordNorwegian PSC Research Centre, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
Johannes R HovNorwegian PSC Research Centre, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
Kirsten BobergNorwegian PSC Research Centre, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
Mette VesterhusNorwegian PSC Research Centre, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
Kristin K JørgensenNorwegian PSC Research Centre, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
Annika BergquistUnit of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Jorn C GoetDepartment of Gastroenterology and Hepatology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Annemarie C de VriesDepartment of Gastroenterology and Hepatology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Adriaan J P van der MeerDepartment of Gastroenterology and Hepatology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Rinse K WeersmaDepartment of Gastroenterology and Hepatology, University Medical Centre Groningen, Groningen, The Netherlands.
Akin IndersonDepartment of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
Johannes A BogaardsDepartment of Epidemiology and Data Science, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Cyriel Y PonsioenDepartment of Gastroenterology and Hepatology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
IPSCR study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Aims: The gut-liver axis is believed to be crucial in the pathogenesis of primary sclerosing cholangitis (PSC). However, the impact of colectomy on liver disease progression is unclear. Our study estimated the effect of colectomy on PSC progression with correction for time dependency and established risk factors by pooling data from several cohorts across different countries. Methods: We analysed data from the International PSC Registry (IPSCR), comprising patients from Finland, The Netherlands, Norway, and Sweden. Primary endpoint was defined as liver transplantation (LT) or PSC-related death. Cox proportional hazards regression onto time-dependent colectomy status, with specification for extent, was performed with adjustment for sex, age at diagnosis, large or small duct PSC, features of autoimmune hepatitis, time-dependent inflammatory bowel disease (IBD) status, centre of inclusion, and country of residence. Results: A total of 3,110 participants were included, of whom 470 (15%) had undergone colectomy. During a total follow-up of 32,236 patient-years, 395 deaths and 653 LTs were observed. Compared with patients with PSC with intact colon, the hazard ratio (HR) of reaching LT or PSC-related death was significantly decreased in patients with proctocolectomy with permanent ileostomy (HR 0.41; 95% CI 0.24-0.71). This effect was less pronounced in case of hemi- or subtotal colectomy (HR 0.81; 95% CI: 0.58-1.12) and not observed for proctocolectomy with pouch (HR 1.00; 95% CI: 0.73-1.38). The reduced risk was mainly associated with a lower rate of LT or death resulting from liver failure (HR 0.24; 0.10-0.53). Conclusions: Proctocolectomy with permanent ileostomy was associated with decreased risk for LT and PSC-related death. These findings support the role of the gut-liver axis in the pathophysiology of PSC and call for consideration in counselling patients who face impending colorectal surgery. Impact and implications: The impact of the gut-liver axis in the pathophysiology of primary sclerosing cholangitis (PSC) has remained uncertain. In this study, proctocolectomy with ileostomy was associated with improved transplant-free survival, defined as a reduced risk of liver transplantation or PSC-related death, indicating that intestinal factors may influence disease progression. These findings are important for clinicians, researchers, and patients as they suggest that surgical management of colonic disease may have prognostic implications in PSC, and for further studies to clarify mechanisms and guide clinical decision-making.

Indexed as

ColectomyInflammatory bowel diseasePrimary sclerosing cholangitis

Identifiers

PMID41757378
PMCPMC12934274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.